United States - English - NLM (National Library of Medicine)

synergy pharmaceuticals inc. - plecanatide (unii: 7ik8z952ok) (plecanatide - unii:7ik8z952ok) - plecanatide 3 mg - trulance is indicated in adults for the treatment of: trulance is contraindicated in: risk summary plecanatide and its active metabolite are negligibly absorbed systemically following oral administration [see clinical pharmacology (12.3)] and maternal use is not expected to result in fetal exposure to the drug. the available data on trulance use in pregnant women are not sufficient to inform any drug-associated risks for major birth defects and miscarriage. in animal developmental studies, no effects on embryo-fetal development were observed with oral administration of plecanatide in mice and rabbits during organogenesis at doses much higher than the recommended human dosage. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the united states general population, the estimated background risk of major birth defects and miscarriage in clinically recognized

United States - English - NLM (National Library of Medicine)

salix pharmaceuticals inc. - plecanatide (unii: 7ik8z952ok) (plecanatide - unii:7ik8z952ok) - trulance is indicated in adults for the treatment of: trulance is contraindicated in: risk summary plecanatide and its active metabolite are negligibly absorbed systemically following oral administration [see clinical pharmacology (12.3)] and maternal use is not expected to result in fetal exposure to the drug. the available data on trulance use in pregnant women are not sufficient to inform any drug-associated risks for major birth defects and miscarriage. in animal developmental studies, no effects on embryo-fetal development were observed with oral administration of plecanatide in mice and rabbits during organogenesis at doses much higher than the recommended human dosage. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the united states general population, the estimated background risk of major birth defects and miscarriage in clinically recognized

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lloyds pharmacy ltd - ranitidine hydrochloride - oral tablet - 75mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lloyds pharmacy ltd - ranitidine hydrochloride - oral tablet - 75mg

Australia - English - Department of Health (Therapeutic Goods Administration)

noumed pharmaceuticals pty ltd - pseudoephedrine hydrochloride, quantity: 60 mg - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate dihydrate; magnesium stearate; microcrystalline cellulose - fast temporary relief from a runny nose and reduce the swollen membranes of the nose and sinuses and helping breathe freely.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - ibuprofen, quantity: 200 mg; paracetamol, quantity: 500 mg - tablet, film coated - excipient ingredients: hypromellose; crospovidone; pregelatinised maize starch; titanium dioxide; microcrystalline cellulose; colloidal anhydrous silica; purified talc; magnesium stearate; povidone; purified water; polysorbate 80; polyvinyl alcohol; macrogol 3350; mica - temporary relief of acute (short term) pain and / or inflammation associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, muscular aches and pains, period pain, sore throat, tennis elbow, rheumatic pain and arthritis, and the aches and pains associated with colds and flu. reduces fever.

Canada - English - Health Canada

bausch health, canada inc. - plecanatide - tablet - 3mg - plecanatide 3mg - miscellaneous gi drugs

Bangladesh - English - DGDA (Directorate General of Drug Administration)

bengal homoeopathic laboratory - sabal serrulata - liquid

Bangladesh - English - DGDA (Directorate General of Drug Administration)

dhaka homoeo hall (pvt) ltd. - sabal serrulata - liquid

Bangladesh - English - DGDA (Directorate General of Drug Administration)

new life & company (pvt) ltd. (homoeo) - sabal serrulata - liquid